Another randomized clinical trial in patients with resectable mCRC used autologous tumor lysate-pulsed DCs and CD40L.377 After tumor resection, the tumor was irradiated and lysed in three freeze–thaw cycles in liquid nitrogen. Here, CD40LG is linked to neoplasm.